SeaStar Medical Forum: Community User: Standard

Was denkste wie es hier im September weitergeht? Den 1$ müssten wir jetzt endlich mal knacken und das langfristig halten

Jupp. Ich hoffe wir bekommen bald die ersehnten News 🥳

Wird langsam

Top. 👍

338k

300k https://finviz.com/news/139825/seastar-medical-reports-second-quarter-2025-financial-results-and-provides-business-updates

SeaStar Medical Holding Corp ICU.OQ ICU.O is expected to show a rise in quarterly revenue when it reports results on August 13 for the period ending June 30 2025 The Denver Colorado-based company is expected to report revenue of $200 thousand, according to the estimate from one analyst, based on LSEG data. ​LSEG's mean analyst estimate for SeaStar Medical Holding Corp is for a loss of 43 cents per share. The one available analyst rating on the shares is "buy". The mean earnings estimate of analysts was unchanged in the last three months. ​ Wall Street's median 12-month price target for SeaStar Medical Holding Corp is $7.00, about 88.9% above its last closing price of $0.78 200k wàre ein Rúckgang mal sehen

gebe letzte Chance bis ER im August. Wäre klasse wenn doch noch RS kommt dann bist komplett gef.

Die elendigen wieder offering https://finviz.com/news/123493/seastar-medical-announces-44-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules

Sieht doch gut aus 💪🏻

https://www.globenewswire.com/news-release/2025/07/22/3119402/0/en/SeaStar-Medical-Reports-Positive-Results-for-QUELIMMUNE-Therapy-in-Pediatric-Acute-Kidney-Injury-AKI-from-the-First-20-SAVE-Surveillance-Registry-Patients.html

Läuft iwas an

Bin da zu 0.64$ mit einer kleinen Position rein. Lieber kaufe ich bei 2$ bei gutem Ausblick nach, als wie zuvor voll drin zu sein und -50% zu schließen. 😅

Auf interessanter Ansatz aus Stocktwits $ICU I just had to ask... # # The machine in the photo is the PrisMax CRRT system— Baxter’s recommended platform for use with this extracorporeal device. Baxter International is a global medical products firm known for its wide range of renal care systems— including continuous renal replacement therapy (CRRT) # # Would it make business sense for Baxter to buy out Seastar Medical? What would be the likely buyout price? Could Baxter afford it? # # -Yes—there’s a compelling business rationale: ▸ Technology Alignment: SeaStar’s Selective Cytopheretic Device (SCD) is designed to run on Baxter’s own CRRT platforms. This integration reduces adoption friction and positions Baxter to own the full treatment ecosystem—from machine to filter cartridge to therapy. -A near-term buyout (within 6 months) would likely be in the $100–150 million range. -Can Baxter afford it? Absolutely. Baxter's 2024 financials (approx): Annual revenue: $14B Cash on hand: $1.5–2B Market cap: $20–25B

Müsste Nr. 6 sein https://www.linkedin.com/posts/kevin-chung-5a0a964_save-quelimmune-activity-7351362745998450689-pS4B

https://finviz.com/news/105119/seastar-medical-grows-customer-base-and-expands-quelimmune-surveillance-registry